Indivior Pharmaceuticals, Inc. Common Stock

INDVNASDAQUSD
35.70 USD
0.13 (0.35%)🟢PRE MARKET (AS OF 04:13 AM EDT)
🟢Market: OPEN

INDV is currently priced at $35.70. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation side, INDV appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Aug 26, 2026.

Open?$36.00
High?$36.00
Low?$35.09
Prev. Close?$35.83
Volume?429
Avg. Volume?2.2M
VWAP?$35.50
Rel. Volume?0.00x
Bid / Ask
Bid?$30.53 × 100
Ask?$42.18 × 100
Spread?$11.65
Midpoint?$36.36
Valuation & Ratios
Market Cap?4.2B
Shares Out?N/A
Float?109.8M
Float %?93.0%
P/E Ratio?11.91
P/B Ratio?-20.33
EPS?$3.01
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
Employees
838
Market Cap
4.2B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2014-12-24
Address
10710 MIDLOTHIAN TURNPIKE
NORTH CHESTERFIELD, VA 23235
Phone: 804-379-1090
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-1/3)
Medium-Term (Wave)? Bearish(-3/3)
Short-Term (Ripple)? Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
83
Momentum?
88
Short Sent.?
60
Piotroski F-Score?0/9Weak
Altman Z-Score?3.45Safe
Confidence?49%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?9.51%Elevated
Short Interest?10.4M
Days to Cover?3.3
Free Float109.8M
Avg Daily Volume3.2M
Settlement Date2026-08-14
Financial Health
Current Ratio?0.84Weak
Quick Ratio?0.66Weak
Cash Ratio?0.26Low
Debt/Equity?-2.34Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
87/100
P/E?
Peers
100
S&P
91
11.9CHEAP
P/B?
S&P
97
-20.33CHEAP
P/S?
Peers
100
S&P
48
3.17FAIR
P/FCF?
N/A
EV/EBITDA?
Peers
100
S&P
78
10.4CHEAP
EV/Sales?
Peers
100
S&P
55
3.37FAIR
Returns & Efficiency
ROE?
S&P
3
-170.7%WEAK
ROA?
Peers
50
S&P
97
28.8%STRONG
Cash Flow & Enterprise
FCF?$-111000000
Enterprise Value?$4.5B
Fundamentals ratios updated end of day